Experience of neoadjuvant selective intraarterial chemotherapy in accordance to FOLFIRINOX scheme, conducted in a patient, suffering a conditionally resectable cancer of the right anatomo-surgical segment of pancreatic gland


Abstract

Experience of neoadjuvant selective intraarterial chemotherapy in accordance to FOLFIRINOX scheme, conducted in a patient, suffering a conditionally resectable cancer of the right anatomo-surgical segment of pancreatic gland

References

1. Milandri C. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience. Hepatogastroenterology. 2007 Dec;54 (80):2373-7. PMID: 18265668.

2. Liu F, Tang Y, Sun J, Yuan Z, Li S, Sheng J, Ren H, Hao J. Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2012;7(7): e40847. doi:10.1371/journal.pone.0040847.

3. Ma N, Wang Z, Zhao J, Long J, Xu J, Ren Z, et al. Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy. Medical Science Monitor. 2017 May;23:2315-23. doi: 10.12659/MSM.904393.

4. Liu X, Yang X, Zhou G, Chen Y, Li C, Wang X. Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma. Medicine (Baltimore). 2016 Mar;95(11):е3098. doi:10.1097/MD.0000000000003098.

5. Hashimoto A, Tanaka T, Sho M, Nishiofuku H, Masada T, Sato T, et al. Adjuvant Hepatic Arterial Infusion Chemotherapy After Resection for Pancreatic Cancer Using Coaxial Catheter-Port System Compared with Conventional System. Cardiovasc Intervent Radiol. 2016 Jun;39(6):831-9. doi:10.1007/s00270-016-1292-7.

6. Nakayama A, Tajima H, Kitagawa H, Shoji M, Nakanuma S, Makino I, et al. A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer. Gan To Kagaku Ryoho. 2014 Nov;41(12):2205-7. PMID: 25731471. [In Japanese].

7. Zheng YY, Tang CW, Xu YQ, Feng WM, Bao Y, Fei MY. Hepatic arterial infusion chemotherapy reduced hepatic metastases from pancreatic cancer after pancreatectomy. Hepatogastroenterology. 2014 Jul-Aug:61(133):1415-20. PMID: 25436319.

8. Beane JD, Griffin KF, Levy EB, Pandalai P, Wood B, Abi-Jaoudeh N, Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study. Invest New Drugs. 2015:33(1):109-18. doi:10.1007/s10637-014-0157-7.

9. Chen Y, Wang XL, Wang JH, Yan ZP, Cheng JM, Gong GQ, et al. Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer. Anticancer Drugs. 2014 Sep;25(8):958-63.doi:10.1097/CAD.0000000000000120.

10. Doi T, Homma H, Akiyama T, Mezawa S, Takahashi M, Ohi M, et al. Clinical Significance of Adjuvant Surgical Resection for Initially Unresectable Pancreatic CancerResponsive to Arterial Infusion Chemotherapy. Hepatogastroenterology. 2014 May;61(131):828-33. PMID: 26176081.

11. Hong GB, Zhou JX, Sun HB, Li CY, Song LQ. Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma. Asian Pac J Cancer Prev. 2012:13(6):2669-73. PMID: 22938439.

12. Heinric S, Kraft D, Staib-Sebler E, Schwarz W, Gog C, Vogl T, et al. Phase II study on combined intravenous and intra-arterial chemotherapy with gemcitabine and mitomycin C in patients with advanced pancreatic cancer. Hepatogastroenterology. 2013:60(126):1492-1496. doi:10.5754/hge11805.

Author Biographies


M. S. Zagriichuk, Shalimov National Institute of Surgery and Transplantology, Kyiv

Zagriichuk Mykhaylo Stepanovich, MD, PhD, surgeon;

Department of pancreatic surgery, laparoscopic and reconstructive surgery of bile duct;  

Shalimov National Institute of Surgery and Transplantology,

30 Heroev Sevastopolya str., Kiev, Ukraine

+38 (044) 454 20 18

Shalimov-org@ukr.net

https://orcid.org/0000-0001-8051-8771


V. A. Kondratyk, Shalimov National Institute of Surgery and Transplantology, Kyiv

Kondratyk Vadim Anatoliyovich, MD, PhD, Endovascular surgeon

Department of endovascular surgery;   

Shalimov National Institute of Surgery and Transplantology,

30 Heroev Sevastopolya str., Kiev, Ukraine

+38 (044) 454 20 18

vkondr@gmail.com

https://orcid.org/0000-0002-2506-5009


Ya. V. Romaniv, Shalimov National Institute of Surgery and Transplantology, Kyiv

Romaniv Yaroslav Volodumurovich, MD, anesthesiologist;

Department of anesthesiology and intensive care unit;

Shalimov National Institute of Surgery and Transplantology,

30 Heroev Sevastopolya str., Kiev, Ukraine

+38 (044) 454 20 18

Doctor0765@gmail.com

https://orcid.org/0000-0001-7158-9631


Yu. V. Nezhentseva, Shalimov National Institute of Surgery and Transplantology, Kyiv

Nezhentseva YuliaValeriivna, MD, PhD, surgeon;

Department of pancreatic surgery, laparoscopic and reconstructive surgery of bile duct;

Shalimov National Institute of Surgery and Transplantology,

30 Heroev Sevastopolya str., Kiev, Ukraine

+38 (044) 454 20 18 моб. 0961585137

vvvrrr15@ukr.net

https://orcid.org/0000-0001-6391-4916


O. O. Pidopryhora, Shalimov National Institute of Surgery and Transplantology, Kyiv

Pidopryhora Olena Oleksandrivna, MD, PhD, surgeon;

Department of pancreatic surgery, laparoscopic and reconstructive surgery of bile duct; Shalimov National Institute of Surgery and Transplantology,

30 Heroev Sevastopolya str., Kiev, Ukraine

+38 (044) 454 20 18

podop-elena@ukr.net

https://orcid.org/0000-0002-1657-2973

Published
2019-01-30
How to Cite
Zagriichuk, M. S., Kondratyk, V. A., Romaniv, Y. V., Nezhentseva, Y. V., & Pidopryhora, O. O. (2019). Experience of neoadjuvant selective intraarterial chemotherapy in accordance to FOLFIRINOX scheme, conducted in a patient, suffering a conditionally resectable cancer of the right anatomo-surgical segment of pancreatic gland. Klinicheskaia Khirurgiia, 86(1), 69-72. https://doi.org/10.26779/2522-1396.2019.01.69
Section
Brief Communications

Most read articles by the same author(s)